Inverness Medical Innovations Hong Kong Ltd.， also known as IMIHK is part of Alere Inc.， USA – a world leader in Point of Care Testing In-vitro Diagnostics. Alere Inc.， USA is a New York exchange listed company with approximately $2.1 billion USD sales in 2010. IMIHK is committed to provide our business partners with Cost-Effective solutions. These solutions will help them achieve unparallel opportunity of growth by earning a significant share of the market with our high quality products. IMIHK is now covering ABON branded lateral flow diagnostic products in Asia Pacific， Latin America， South America， the Middle East， Africa， India， Pakistan， Russia， and parts of Eastern Europe territories. IMIHK product portfolio mainly encompasses Drugs of Abuse， Women's Health， Infectious Diseases， Oncology and Cardiology testing. Most of our products are US FDA cleared and CE-Marked. Alere's mission is To empower individuals with the freedom to gain greater control over their own health. To enable healthcare providers to improve clinical outcomes and lower costs. To deliver to our investors significant annual earnings growth for the next several years. As part of Alere family， IMIHK would like to follow the company mission and provide you with better technology， better products and better health solution in today's competitive and fast growing environment. Please visit us for more details here， .